PTC Therapeutics wins FDA nod for gene therapy
PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...
PipelineReview.com15h
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
WARREN, NJ, USA I November 13, 2024 I PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) accelerated approval of its gene therapy for the treatment of ...
阿思達克財經網16h
WUXI BIO (02269.HK) Plans to Expand Capabilities in Germany w/ New PFS Line
WUXI BIO (02269.HK) announced that it will enhance its drug product (DP) capabilities at the company’s facility in Leverkusen ...
Reuters23h
US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder
PTC Therapeutics' gene therapy is already approved in the ... Reuters provides business, financial, national and ...